- Home
- THO vs TMDX Comparison
THO vs TMDX Comparison
Compare THO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THO
- TMDX
- Stock Information
- Founded
- THO 1980
- TMDX 1998
- Country
- THO United States
- TMDX United States
- Employees
- THO N/A
- TMDX N/A
- Industry
- THO Homebuilding
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- THO Industrials
- TMDX Health Care
- Exchange
- THO Nasdaq
- TMDX Nasdaq
- Market Cap
- THO 5.7B
- TMDX 4.7B
- IPO Year
- THO N/A
- TMDX 2019
- Fundamental
- Price
- THO $109.41
- TMDX $88.36
- Analyst Decision
- THO Buy
- TMDX Buy
- Analyst Count
- THO 6
- TMDX 10
- Target Price
- THO $110.80
- TMDX $138.20
- AVG Volume (30 Days)
- THO 491.9K
- TMDX 2.2M
- Earning Date
- THO 12-04-2024
- TMDX 10-28-2024
- Dividend Yield
- THO 1.81%
- TMDX N/A
- EPS Growth
- THO N/A
- TMDX N/A
- EPS
- THO 4.94
- TMDX 0.94
- Revenue
- THO $10,043,408,000.00
- TMDX $401,090,000.00
- Revenue This Year
- THO N/A
- TMDX $83.25
- Revenue Next Year
- THO $6.92
- TMDX $26.27
- P/E Ratio
- THO $22.32
- TMDX $94.29
- Revenue Growth
- THO N/A
- TMDX 109.09
- 52 Week Low
- THO $88.37
- TMDX $63.86
- 52 Week High
- THO $129.31
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- THO 51.64
- TMDX 31.88
- Support Level
- THO $108.25
- TMDX $82.70
- Resistance Level
- THO $116.40
- TMDX $98.88
- Average True Range (ATR)
- THO 3.85
- TMDX 5.52
- MACD
- THO 0.24
- TMDX 1.30
- Stochastic Oscillator
- THO 45.56
- TMDX 15.58
About THO Thor Industries Inc.
Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth wheel towables across over 30 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motorcaravans, campervans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts through the acquisition of Airxcel in 2021, however, this is still a nascent part of the business as it accounts for less than 10% of total sales. In fiscal 2023, the company wholesaled 187,015 units and generated over $11.1 billion in revenue.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.